Exact Mass: 572.3209833999999
Exact Mass Matches: 572.3209833999999
Found 59 metabolites which its exact mass value is equals to given mass value 572.3209833999999,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
12(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside J
12(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside J
13(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside I
13(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside I
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone
NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based: Match]
NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based: Match]
1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based on: CCMSLIB00000845569]
NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based on: CCMSLIB00000845569]
Asn Gln Arg Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid
Asn Arg Gln Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid
Asn Arg Arg Gln
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid
Gln Asn Arg Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid
Gln Arg Asn Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid
Gln Arg Arg Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid
Arg Asn Gln Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid
Arg Asn Arg Gln
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid
Arg Gln Asn Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid
Arg Gln Arg Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid
Arg Arg Asn Gln
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid
Arg Arg Gln Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid
ethyl (2E,4S)-4-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]-4-methylpentanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate
ethyl (2E,4S)-4-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]-4-methylpentanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate
C30H44N4O7 (572.3209833999999)
Arg-Asn-Gln-Arg
Arg-Asn-Gln-Arg
A tetrapeptide composed of L-arginine, L-asparagine, L-glutamine, and L-arginine joined in sequence by peptide linkages.
LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.
[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol
[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol
3-{[(2r,3r,4s,4ar,18r,19ar)-2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl]oxy}-3-oxopropanoic acid
3-{[(2r,3r,4s,4ar,18r,19ar)-2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl]oxy}-3-oxopropanoic acid
(2s,3s,4r,5r,6r)-3,5-dihydroxy-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-4-yl acetate
(2s,3s,4r,5r,6r)-3,5-dihydroxy-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-4-yl acetate
3-({2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl}oxy)-3-oxopropanoic acid
3-({2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl}oxy)-3-oxopropanoic acid
3,5-dihydroxy-2-methyl-6-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-4-yl acetate
3,5-dihydroxy-2-methyl-6-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-4-yl acetate
[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol
[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol
3-({2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl}oxy)-3-oxopropanoic acid
3-({2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl}oxy)-3-oxopropanoic acid
1,5,11,15,21,25-hexahydroxy-1,6,11,16,21,26-hexaazacyclohentriaconta-5,15,25-triene-2,12,22-trione
1,5,11,15,21,25-hexahydroxy-1,6,11,16,21,26-hexaazacyclohentriaconta-5,15,25-triene-2,12,22-trione
(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate
(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate
3-{[(2r,3r,4s,4ar,17r,18ar)-2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl]oxy}-3-oxopropanoic acid
3-{[(2r,3r,4s,4ar,17r,18ar)-2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl]oxy}-3-oxopropanoic acid
(11e,13e)-16-ethyl-4,6,7-trihydroxy-15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione
(11e,13e)-16-ethyl-4,6,7-trihydroxy-15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione
(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate
(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate
4,5-dihydroxy-6-methyl-2-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-3-yl acetate
4,5-dihydroxy-6-methyl-2-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-3-yl acetate